Investigating the Efficiency of APRI, FIB-4, AAR and AARPRI as Noninvasive Markers for Predicting Hepatic Fibrosis in Chronic Hepatitis B Patients in Bangladesh

Table 2: Correlation between METAVIR fibrosis stages and non-invasive markers in training cohort.

Variables	Pearson Correlation, r	P value
Age	0.313	<0.001
ALT(U/L)	0.490	<0.001
AST(U/L)	0.640	<0.001
HBV DNA(IU/L)	0.066	0.115
Hb(g/dl)	-0.242	<0.001
WBC(10^3/µl)	-0.255	<0.001
PLT(10^3/µl)	-0.448	<0.001
RDW (%)	0.282	<0.001
RBC(10^6/µl)	-0.353	<0.001
FIB-4	0.764	<0.001
APRI	0.850	<0.001
AAR	0.397	<0.001
AARPRI	0.628	<0.001

FIB-4; Fibrosis-4, APRI; AST to Platelet ratio index, AAR; AST to ALT ratio, AARPRI; AAR to Platelet ratio, AST; Aspartate aminotransferase, ALT; Alanine aminotransferase. * denotes significance at p value <0.05.